Insights into the mechanism, structure and potential as drug target of the mycobacterial bd-type terminal oxidase
Mycobacterium tuberculosis, the causative agent of tuberculosis, possesses two terminal oxidases, the cytochrome bcc:aa3 (cyt-bcc:aa3) and the cytochrome bd (cyt-bd). While the cyt-bcc:aa3 is the target of the drug candidate Q203, the cyt-bd remains poorly understood. This work aimed to study the st...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis-Doctor of Philosophy |
| Language: | English |
| Published: |
Nanyang Technological University
2022
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/161580 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Nanyang Technological University |
| Language: | English |
| Summary: | Mycobacterium tuberculosis, the causative agent of tuberculosis, possesses two terminal oxidases, the cytochrome bcc:aa3 (cyt-bcc:aa3) and the cytochrome bd (cyt-bd). While the cyt-bcc:aa3 is the target of the drug candidate Q203, the cyt-bd remains poorly understood. This work aimed to study the structure and function of the mycobacterial cyt-bd. Site-directed mutagenesis was used to identify unique functionally important regions of the cyt-bd. Attempts to purify the cyt-bd to resolve its structure were made. However, the complex could not be obtained in its intact form despite multiple attempts and optimizations. The involvement of the cyt-bd in the synergy between Q203 and clofazimine, an antitubercular drug, was evaluated, leading to a better understanding of the complex modes of action of clofazimine. In conclusion, the work presented in this thesis contributes to knowledge about the mycobacterial cyt-bd, from its structural features to its role in modulating potency of drugs, such as clofazimine. |
|---|